Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-08-19
    E.g., 2018-08-19

Archive Search

1 results
12:00 AM, Apr 12, 2010  |  BC Week In Review | Company News  |  Deals

Altheos, Asahi Kasei Pharma deal

Asahi Kasei granted Altheos exclusive, worldwide rights, excluding Japan and Korea, to develop and commercialize ATS907
for all indications. ATS907, a Rho kinase inhibitor, is in preclinical development to treat glaucoma. The …